Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy

用于预防艾滋病毒和怀孕的双适应症阴道环中药物成分的表征

• 批准号: 10697056
• 负责人: PETER SILVERA
• 金额: $ 45.51万
• 依托单位: ADVANCED BIOSCIENCE LABORATORIES, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10697056
• 关键词: AIDS prevention; Animal Model; Area; Characteristics; Collaborations; Contractor; Contracts; Dapivirine; Dosage Forms; HIV; Investigator-Initiated Research; Levonorgestrel; Morphology; National Institute of Allergy and Infectious Disease; Pharmaceutical Preparations; Pregnancy; Prevention; Resources; Services; Technology; Vaginal Ring; microbicide; particle; pre-clinical; product development; research study

The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.